| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC22883 | MK-7288 | A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome. |
|
| DC24012 | BI-224436 | A novel HIV-1 non-catalytic-site integrase inhibitor (NCINI). |
|
| DC22944 | NS-3623 Featured | A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation). |
|
| DC23936 | IQ-R | A novel hypoxia-sensitive fluorescent probe. |
|
| DC22386 | I-2906 | A novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity. |
|
| DC25013 | ARM-1 Featured | A novel LTA4 hydrolase (LTA4H) inhibitor that inhibits LTB4 synthesis in human neutrophils with IC50 of 0.5 uM. |
|
| DC22856 | ARN-5187 | A novel lysosomotropic REV-ERB ligand that has a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. |
|
| DC21378 | Piromelatine | A novel melatonin melatonin receptor MT1/MT2 and serotonin 5-HT1A/5-HT1D receptor agonist. |
|
| DC22773 | DSR-71167 | A novel mineralocorticoid receptor antagonist (IC50=0.26 uM) with carbonic anhydrase inhibitory activity (IC50=19 uM). |
|
| DC11775 | DS44170716 | A novel MPT (mitochondrial permeability transition) inhibitor of that inhibits Ca2+-induced MPT in rat liver isolated mitochondria. |
|
| DC22955 | LUF7244 | A novel negative allosteric modulator of dofetilide binding to the Kv11.1 (hERG) channel with the strongest effect at 10 uM (IC50=3.9 uM). |
|
| DC20293 | 14-3-3 inhibitor BV2 | A novel nonpeptidic inhibitor of 14-3-3 protein-protein interaction that promotes the apoptotic death of cells expressing either wt Bcr-Abl construct or T315I mutation. |
|
| DC11910 | IPL-576092 | A novel orally active, anti-inflammatory compound that inhibits leukocyte infiltration and changes in lung function in response to allergen challenge. |
|
| DC23994 | Peretinoin | A novel orally available, synthetic retinoid with potential antineoplastic and chemopreventive activities. |
|
| DC24203 | P2X2/3 receptor antagonist Featured | A novel P2X3 and P2X2/3 receptor antagonist useful for the treatment of urinary tract diseases, pain, respiratory diseases and cardiovascular diseases. |
|
| DC22434 | POL5551 | A novel peptidic, potent and highly selective CXCR4 antagonist with IC50 of 1.7 nM. |
|
| DC3161 | Prasugrel Featured | A novel platelet inhibitor |
|
| DC23635 | YM 758 | A novel potent "funny" If current channel (If channel) inhibitor that inhibits rOct1- and hOCT1-mediated [3H]MPP uptake with IC50 of 23.8 and 40.5 uM, respectively. |
|
| DC23542 | LY3031207 | A novel potent (IC50=910 ng/mL), highly selective microsomal prostaglandin E synthase 1 inhibitor (mPGES-1) for treatment of undisclosed indications.. |
|
| DC23841 | EW-7195 Featured | A novel potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 4.83 nM, dispalys >300-fold selectivity over p38α. |
|
| DC22734 | UR-1102 | A novel potent and selective, orally active URAT1 inhibitor with Ki of 57 nM, 130 and 42-fold selectivity over OAT1 and OAT3, respectively. |
|
| DC20826 | BPR1K653 hydrochloride | A novel potent Aurora kinase inhibitor that inhibits Aurora-A and Aurora-B with IC50 of 24 nM and 45 nM, respectively. |
|
| DC21048 | GIV3727 | A novel potent bitter receptor (TAS2Rs) antagonist that inhibits activation of hTAS2R31 by saccharin and acesulfame K with IC50 of 6.4 and 7.9 uM respectively. |
|
| DC20534 | Revosimeline | A novel potent cannabinoid receptor agonist.. |
|
| DC20435 | Leucettine L41 | A novel potent cdc2-like kinase (CLKs) and DYRKs inhibitor with IC50 of 40, 35 and 15 nM for DYRK1A, DYRK2 and CLK1, respectively. |
|
| DC21453 | Riviciclib | A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively. |
|
| DC22743 | OSSK-674842 | A novel potent CFTR potentiator that blocks hCFTR with apparent Kd of 71.3 uM. |
|
| DC22739 | OSSK-630513 | A novel potent CFTR potentiator with Kd of 31.7 nM. |
|
| DC21855 | ZINC 39395747 Featured | ZINC 39395747 is a novel potent derivative of propylthiouracil that functions as a cell-active inhibitor of cytochrome b5 reductase 3 (CYB5R3) with IC50 of 9.14 uM. |
|
| DC20437 | Linzagolix | A novel potent gonadotrophin releasing hormone (GnRH) antagonist.. |
|
